Percutaneous Pulmonary Valve

  • Mark S. Turner
  • Mario Carminati
  • Philipp Bonhoeffer


Tetralogy of Fallot (ToF) and its surgical treatment frequently lead to dysfunction of the pulmonary valve. A common surgical approach to this is to implant a right ventricle to pulmonary artery valved conduit. Many conduits are available and their nature is important when considering a transcatheter valve. Pulmonary or aortic homografts (human donor valves) have been successfully used as a right ventricle to pulmonary artery conduit [1]. These conduits can fail causing progressive stenosis, or regurgitation, which can present at an early stage. Homografts are prone to calcification as well as endocarditis. Other conduits have been used including pericardial valves mounted in a prosthetic tube, such as a Hancock conduit (porcine) and a valved conduit of bovine jugular vein (Contegra). When a conduit is not needed some surgeons use stented bioprosthetic valves with pericardial leaflets to achieve a competent pulmonary valve [2].


Pulmonary Valve Stent Fracture Venous Valve Transcatheter Valve Transannular Patch 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Van de Woestijne PC, Mokhles MM, de Long PL et al (2011) Right ventricular outflow tract reconstruction with an allograft conduit in patients after tetralogy of Fallot correction: long-term follow-up. Ann Thorac Surg 92:161–166PubMedCrossRefGoogle Scholar
  2. 2.
    Lee C, Park CS, Lee CH, Kwak JG et al (2011) Durability of bioprosthetic valves in the pulmonary poisiton: long-term follow up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg 142:351–358PubMedCrossRefGoogle Scholar
  3. 3.
    Bonhoeffer P, Boudjemline Y, Saliba Z et al (2000) Percutaneous replacement of pulmonary valve in the right ventricle to pulmonary artery prosthetic conduit with valve dysfunction. Lancet 356:1403–1405PubMedCrossRefGoogle Scholar
  4. 4.
    Khambadkone S, Coats L, Taylor A et al (2005) Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 112:1189–1197PubMedCrossRefGoogle Scholar
  5. 5.
    Coats L, Khambadkone S, Derrick G et al (2006) Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. Circulation 113:2037–2044PubMedCrossRefGoogle Scholar
  6. 6.
    Coats L, Khambadkone S, Derrick G et al (2007) Physiological consequences of percutaneous pulmonary valve replacement; the different behaviour of volume and pressure-overloaded ventricles. Eur Heart J 28:1886–1893PubMedCrossRefGoogle Scholar
  7. 7.
    Eicken A, Ewert P, Hager A et al (2011) Percutaneous pulmonary valve implantation: two centre experience of over 100 patients. Eur Heart J 32:1260–1265PubMedCrossRefGoogle Scholar
  8. 8.
    Sridharan S, Coats L, Khambadkone S et al (2006) Transcatheter right ventricular outflow tract intervention: The risk to the coronary circulation. Circulation 113:e934–935PubMedCrossRefGoogle Scholar
  9. 9.
    Nordmeyer J, Khambadkone S, Coats L et al (2007) Risk stratification, systematic classification, and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation. Circulation 115:1392–1397PubMedCrossRefGoogle Scholar
  10. 10.
    Schievano S, Petrini L, Migliavacca F et al (2007) Finite element analysis of stent deployment: understanding stent fractures in percutaneous pulmonary valve implantation. J Interv Cardiol 20:546–554PubMedCrossRefGoogle Scholar
  11. 11.
    Nordmeyer J, Coats L, Lurz P et al (2008) Percutaneous pulmonary valve-in-valve implantation: a successful treatment concept for early device failure. Eur Heart J 29:810–815PubMedCrossRefGoogle Scholar
  12. 12.
    Nordmeyer J, Lurz P, Khambadkone S et al (2011) Pre-stenting with bare metal stent before percutaneous pulmonary valve implantation: acute and 1-year outcomes. Heart 97:118–123PubMedCrossRefGoogle Scholar
  13. 13.
    Atherton JJ, Moore TD, Lele SS et al (1997) Diastolic ventricular interaction in chronic heart failure. Lancet 349:1720–1724PubMedCrossRefGoogle Scholar
  14. 14.
    Morris-Thurgood JA, Frenneaux MP (2000) Diastolic ventricular interaction and ventricular diastolic filling. Heart Fail Rev 5:307–323PubMedCrossRefGoogle Scholar
  15. 15.
    Lurz P, Puranik R, Nordmeyer J (2009) Improvement in left ventricular filling properties after relief of right ventricle to pulmonary artery conduit obstruction: contribution of septal motion and interventricular mechanical delay. Eur Heart J 30:2266–2274PubMedCrossRefGoogle Scholar
  16. 16.
    . Tobler D, Crean AM, Redington AN et al (2011) The left heart after pulmonary valve replacement in adults late after tetralogy of Fallot repair. Int J Cardiol [Epub ahead of print]Google Scholar
  17. 17.
    Roche SL, Grosse-Wortmann L, Redington AN et al (2010) Exercise induces biventricular mechanical dyssynchrony in children with repaired tetralogy of Fallot. Heart 96:2010–2015PubMedCrossRefGoogle Scholar
  18. 18.
    Bleasdale RA, Turner MS, Mumford CE et al (2004) Left ventricular pacing minimizes diastolic ventricular interaction, allowing improved preload-dependent systolic performance. Circulation 110:2395–2400PubMedCrossRefGoogle Scholar
  19. 19.
    Ghai A, Silversides C, Harris L et al (2002) Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol 40:1675–1680PubMedCrossRefGoogle Scholar
  20. 20.
    Frigiola A, Tsang V, Bull C et al (2008) Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome? Circulation 118:S182–190PubMedCrossRefGoogle Scholar
  21. 21.
    Schievano S, Taylor AM, Capelli C et al (2010) First-in-man implantation of a novel percutaneous valve: a new approach to medical device development. Euro Intervention 5:745–750PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Mark S. Turner
    • 1
  • Mario Carminati
  • Philipp Bonhoeffer
  1. 1.Department of CardiologyBristol Heart InstituteBristolUK

Personalised recommendations